Michael R. Minogue

This profile gathers the share dealings of Michael R. Minogue across 4 companies, led by Abiomed Inc, Insulet Corp and Lifecell Corp. Between 31 March 2006 and 25 February 2026, the trades on record add up to 324 filings.

Market trades split into 2 purchases (€1.4M) and 111 sales (€140.6M). Sales outweigh purchases by €139.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 103 share grants and 43 option exercises. In 2026 alone, the filings show 1 purchase and no sales.

Most recently, on 26 February 2026, the filings show an open-market purchase worth €424k in Insulet Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.